Back
Virtus LifeSci Biotech Clinical Trls ETF Vs. Range Cancer Therapeutics ETF Industry Stock Comparison
Buy
75
BBC
Virtus LifeSci Biotech Clinical Trls ETF
Last Price:
27.33
Seasonality Move:
4.24%
Buy
54
CNCR
Range Cancer Therapeutics ETF
Last Price:
15.50
Seasonality Move:
4.46%
Buy
75
Virtus LifeSci Biotech Clinical Trls ETF (BBC)
is a Buy
Is Virtus LifeSci Biotech Clinical Trls ETF a Buy, Sell or Hold?
- The current Virtus LifeSci Biotech Clinical Trls ETF [BBC] share price is $27.43. The Score for BBC is 75, which is 50% above its historic median score of 50, and infers lower risk than normal.
- BBC is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
54
Range Cancer Therapeutics ETF (CNCR)
is a Buy
Is Range Cancer Therapeutics ETF a Buy, Sell or Hold?
- The current Range Cancer Therapeutics ETF [CNCR] share price is $15.24. The Score for CNCR is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- CNCR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BBC Stock Price Chart
What is Virtus LifeSci Biotech Clinical Trls ETF's stock price today?
-
The Virtus LifeSci Biotech Clinical Trls ETF share price today is $27.43
The current trend is moderately bullish and BBC is experiencing selling pressure, which indicates risk of future bearish movement.
CNCR Stock Price Chart
What is Range Cancer Therapeutics ETF's stock price today?
-
The Range Cancer Therapeutics ETF share price today is $15.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CNCR is experiencing slight selling pressure.
BBC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.06 | Buy |
| Relative Strength Index (14 RSI): | 53.34 | Buy |
| Chaikin Money Flow: | -7974 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.55 - 27.71) | Buy |
| Bollinger Bands (100): | (24.69 - 29.01) | Buy |
CNCR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0 | Sell |
| Relative Strength Index (14 RSI): | 49.39 | Sell |
| Chaikin Money Flow: | -276 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.44 - 15.72) | Buy |
| Bollinger Bands (100): | (13.79 - 16.41) | Buy |
BBC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.41 | Buy |
| 20-day SMA: | 26.37 | Buy |
| 50-day SMA: | 27.95 | Sell |
| 200-day SMA: | 23.53 | Buy |
| 8-day EMA: | 27.31 | Buy |
| 20-day EMA: | 26.99 | Buy |
| 50-day EMA: | 27.1 | Buy |
| 200-day EMA: | 25.14 | Buy |
CNCR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 15.47 | Sell |
| 20-day SMA: | 14.92 | Buy |
| 50-day SMA: | 15.8 | Sell |
| 200-day SMA: | 13.14 | Buy |
| 8-day EMA: | 15.37 | Sell |
| 20-day EMA: | 15.25 | Sell |
| 50-day EMA: | 15.31 | Sell |
| 200-day EMA: | 14.12 | Buy |
Virtus LifeSci Biotech Clinical Trls ETF Earnings Growth & BBC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Range Cancer Therapeutics ETF Earnings Growth & CNCR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Virtus LifeSci Biotech Clinical Trls ETF Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Range Cancer Therapeutics ETF Technical Analysis
| Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||